Bill Text: HI SB2718 | 2018 | Regular Session | Introduced
Bill Title: Relating To Cannabis For Medical Use.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2018-02-13 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC/WAM. [SB2718 Detail]
Download: Hawaii-2018-SB2718-Introduced.html
|
THE SENATE |
S.B. NO. |
2718 |
|
TWENTY-NINTH LEGISLATURE, 2018 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO CANNABIS for medical use.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that Act 241, Session Laws of Hawaii 2015, codified as chapter 329D, Hawaii Revised Statutes, established a license scheme for a statewide system of medical cannabis dispensaries to ensure access to medical cannabis for qualifying patients and was later amended by Act 230, Session Laws of Hawaii 2016, and Acts 41 and 170, Session Laws of Hawaii 2017.
The legislature further finds that additional amendments to the law are necessary for various reasons: to clarify legislative intent, to ensure smooth administration of the law, to allow for adequate patient access based on discussions of the working group established by Act 230, Session Laws of Hawaii 2016, identifying other states that have a reasonable medical cannabis program, and the need to resolve issues that have arisen under the current law.
The purpose of this Act is to:
(1) Amend the reciprocity program, whereby qualifying patients from other jurisdictions may purchase limited quantities of cannabis for medical use, subject to certain safeguards, reporting and transparency requirements, and payment of a visiting patient certifying fee;
(2) Extend the maximum period of validity of a qualifying patient's written certification of a debilitating medical condition;
(3) Allow a bona fide physician-patient or advanced practice registered nurse-patient relationship to be established via telehealth;
(4) Add certain devices that provide safe pulmonary administration to the list of medical cannabis products that may be manufactured and distributed;
(5) Increase the tetrahydrocannabinol limit per pack or container of certain manufactured cannabis products;
(6) Exempt from the background check requirement employees of a dispensary or subcontracted production center or retail dispensing location without direct access, contact, or exposure to any cannabis or manufactured cannabis product; and
(7) Condition the department of health's mandatory disclosure of information and documents of dispensaries and production centers, for purposes of verifying qualifying patient information, only upon receipt of a legally authorized subpoena.
SECTION 2. Section 321-30.1, Hawaii Revised Statutes, is amended by amending subsection (b) to read as follows:
"(b) The fund shall consist of all moneys derived
from fees collected pursuant to subsection (c) [and], section
329D-4[.], and section 329D-13(c). There is established within the medical cannabis
registry and regulation special fund:
(1) A medical cannabis registry program sub-account, into which shall be deposited all fees collected pursuant to subsection (c); and
(2) A medical cannabis
dispensary program sub-account, into which shall be deposited all fees
collected pursuant to section 329D-4[.] and 329D-13(c)."
SECTION 3. Section 329-121, Hawaii Revised Statutes, is amended by amending the definition of "written certification" to read as follows:
""Written
certification" means the qualifying patient's medical records or a
statement signed by a qualifying patient's physician or advanced practice
registered nurse, stating that in the physician's or advanced practice
registered nurse's professional opinion, the qualifying patient has a
debilitating medical condition and the potential benefits of the medical use of
cannabis would likely outweigh the health risks for the qualifying patient. The department of health may require, through
its rulemaking authority, that all written certifications comply with a
designated form. "Written
certifications" are valid for [only] one year from the time of
signing[.]; provided that the department may allow any certification to be
valid for up to three years when the qualifying patient's physician or advanced
practice registered nurse states that the debilitating medical condition is
chronic in nature."
SECTION 4. Section 329-126, Hawaii Revised Statutes, is amended to read as follows:
"§329-126 Protections afforded to a treating physician or advanced practice registered nurse. (a) No physician or advanced practice registered nurse shall be subject to arrest or prosecution, penalized in any manner, or denied any right or privilege for providing written certification for the medical use of cannabis for a qualifying patient; provided that:
(1) The physician or advanced practice registered nurse has diagnosed the patient as having a debilitating medical condition, as defined in section 329-121;
(2) The physician or advanced practice registered nurse has explained the potential risks and benefits of the medical use of cannabis, as required under section 329-122;
(3) The written certification is based upon the physician's or advanced practice registered nurse's professional opinion after having completed a full assessment of the patient's medical history and current medical condition made in the course of a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship, as applicable; and
(4) The physician or advanced practice registered nurse has complied with the registration requirements of section 329-123.
(b) For purposes of this subsection, a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship may be established via telehealth, as defined in section 453-1.3(j)."
SECTION 5. Section 329D-10, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:
"(a) The types of medical cannabis products that may be manufactured and distributed pursuant to this chapter shall be limited to:
(1) Capsules;
(2) Lozenges;
(3) Pills;
(4) Oils and oil extracts;
(5) Tinctures;
(6) Ointments and skin lotions;
(7) Transdermal patches;
(8) Pre-filled and
sealed containers used to aerosolize and deliver cannabis orally, such as with
an inhaler or nebulizer;[and]
(9) Devices that provide safe pulmonary administration; provided that the heating element of the device is made of inert materials such as glass, ceramic, or stainless steel, and not of plastic or rubber, and there is a temperature control on the device to ensure a sub-combustion temperature; and
[(9)] (10)
Other products as specified by the department."
SECTION 6. Section 329D-11, Hawaii Revised Statutes, is amended by amending subsection (b) to read as follows:
"(b) Any capsule, lozenge, or pill containing cannabis
or its principal psychoactive constituent tetrahydrocannabinol shall be
packaged so that one dose, serving, or single wrapped item contains no more
than ten milligrams of tetrahydrocannabinol; provided that no manufactured cannabis
product that is sold in a pack of multiple doses, servings, or single wrapped
items, nor any containers of oils, shall contain more than a total of one [hundred]
thousand milligrams of tetrahydrocannabinol per pack or container."
SECTION 7. Section 329D-12, Hawaii Revised Statutes, is amended by amending subsection (b) to read as follows:
"(b) This section shall not apply to:
(1) Qualifying
patients and their primary caregivers who enter or remain on the premises of a
retail dispensing location for the purpose of a transaction conducted pursuant
to sections 329D-6 and 329D-13; [or]
(2) Employees of a medical cannabis dispensary or employees of
a subcontracted production center or retail dispensing location when that
person will have no direct access, contact, or exposure to any cannabis or
manufactured cannabis product; provided that the department may still require a
background check for any individual exempt under this paragraph prior to access
on the premises with written notification to the dispensary;
(3) Any other person approved for access and entry by the department; provided that the person will have no direct access, contact, or exposure to any cannabis or manufactured cannabis product, and shall be accompanied at all times on the premises by an authorized employee of the dispensary; provided further that the department may still require a background check for any individual exempt under this paragraph prior to access on the premises with written notification to the dispensary; or
[(2)] (4)
Government officials and employees acting in an official capacity
and employees of a certified laboratory who enter or remain on the premises of
a retail dispensing location or production center for any purpose authorized by
this chapter."
SECTION 8. Section 329D-13, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:
"(c) Beginning on January 1, 2018, this section may
apply to qualifying patients from other states, territories of the United
States, or the District of Columbia; [provided that the patient is verified
as a patient in their home state and registers with the department through a
registration process established by the department.] provided that:
(1) The patient may purchase no more than one ounce of cannabis
for medical use within a period of fifteen consecutive days, or no more than
two ounces of cannabis within a period of thirty consecutive days; and
(2) The
patient presents and provides to a medical cannabis dispensary:
(A) A
government
issued photo identification;
(B) An active United States state or territory issued medical
cannabis card from the patient's home state, or the patient furnishes a written
certification from the patient's primary care physician certifying that the
patient has a debilitating medical condition; and
(C) Payment of a visiting patient certifying fee of $ , which shall be valid for a period of no more than six months and may be renewed prior to expiration every six months for $ ."
A medical cannabis dispensary
shall make reasonable good faith efforts to verify that the patient's
government issued photo identification is valid, the patient's medical cannabis
card or written certification has not expired, and the certifying physician's
license is in good standing with the applicable jurisdiction.
A medical cannabis dispensary
shall make copies of all documents presented and used in the verification of
the patient's eligibility for reciprocity and log all eligible patients into
the computer software
tracking system established pursuant to section 329D-6(j) to ensure
compliance with dispensing limits under this subsection.
A medical cannabis dispensary may
opt to not serve any patients from other jurisdictions."
SECTION 9. Section 329D-20, Hawaii Revised Statutes, is amended to read as follows:
"[[]§329D-20[]] Law
enforcement access to dispensary and production center records. Notwithstanding any other law, the department
may disclose information and documents of medical cannabis dispensaries and
production centers for the purpose of verifying qualifying patient information,
but shall disclose information, documents, and other records regarding
medical cannabis dispensaries and production centers, only upon [request,]
receipt of a legally authorized subpoena, to any state, federal, or
county agency engaged in the criminal investigation or prosecution of
violations of applicable state, county, or federal laws or regulations related
to the operations or activities of a medical cannabis dispensary."
SECTION 10. This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.
SECTION 11. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 12. This Act shall take effect upon its approval.
|
INTRODUCED BY: |
_____________________________ |
|
|
|
Report Title:
Medical Cannabis; Telehealth; Background Checks; Packaging; Law Enforcement; Medical Cannabis Registry and Regulation Special Fund; Reciprocity; Written Certification; Manufactured Cannabis Products
Description:
Amends the reciprocity program, subject to certain safeguards, reporting and transparency requirements, and payment of a visiting patient certifying fee. Extends the maximum period of validity of a qualifying patient's written certification of a debilitating medical condition. Allows a bona fide physician-patient or advanced practice registered nurse-patient relationship to be established via telehealth. Adds certain devices that provide safe pulmonary administration to the list of medical cannabis products that may be manufactured and distributed. Increases the tetrahydrocannabinol limit per pack or container of certain manufactured cannabis products. Exempts from the background check requirement employees of a dispensary or subcontracted production center or retail dispensing location without direct access, contact, or exposure to any cannabis or manufactured cannabis product. Conditions the department of health's mandatory disclosure of information and documents of dispensaries and production centers, for purposes of verifying qualifying patient information, only upon receipt of a legally authorized subpoena.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
